Tradestie Institutional Equity Comparison Engine · Market Close Nov 19, 2026

OFIX vs KIDS: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

OFIX Wins Head-to-Head Institutional Verdict (3–2 across 6 Pillars · 4–4 Matrix Metrics)

OFIX Overall Winner 6-Pillar Tally: OFIX 3 – 2 KIDS (1 Tie) Matrix Metrics: OFIX 4 – 4 KIDS

As of Nov 19, 2026, Orthofix Medical Inc. (OFIX) is the stronger overall head-to-head candidate over OrthoPediatrics Corp. (KIDS) in the Tradestie Institutional Equity Comparison Engine, winning 4–4 core matrix metrics and 3–2 across our 6-pillar institutional scorecard (led by Valuation Multiples, Profitability & Quality, Balance Sheet & Cash Flow). OFIX carries a Unified Composite Score of 47.8/100 (HOLD) at $6.34 (N/M Forward P/E, -2.1% operating margin), whereas KIDS carries 45.1/100 (HOLD) at $32.51 (N/M Forward P/E, -8.2% operating margin).

  • Growth vs. Quality Trade-Off: OFIX earns the overall head-to-head edge with a stronger Unified Composite Score (47.8/100 HOLD vs. KIDS 45.1/100 HOLD) and 1.05β · 85% Vol risk profile, whereas KIDS leads top-line expansion (+18.6% YoY revenue growth, N/M PEG, and 2 of 6 institutional pillars) for higher-beta growth mandates.
  • Technical & Structure Timing Caution: OFIX is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 27.4); meanwhile KIDS trades in a Markup technical trend (UNCLASSIFIED options phase, RSI 64.2). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About OFIX vs KIDS
OFIX NASDAQ Head-to-Head Winner
Orthofix Medical Inc. Common Stock (DE)
Surgical & Medical Instruments & Apparatus
$6.34
-4.08% 1D
Market Cap $269.4M
TTM Revenue $835M
Forward P/E N/M
Beta / 30D Vol 1.05β · 85% Vol
Unified Composite Score
47.8 / 100 HOLD
Tech 45.0 Fund 50.0 Flow 50.0 Mom 55.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -5.9%), weak momentum, RSI 27
RSI-14: 27.4 · SMA20: $8.27 · SMA50: $8.88
KIDS NASDAQ
OrthoPediatrics Corp. Common Stock
Surgical & Medical Instruments & Apparatus
$32.51
+2.72% 1D
Market Cap $850.2M
TTM Revenue $264M
Forward P/E N/M
Beta / 30D Vol 0.81β · 108% Vol
Unified Composite Score
45.1 / 100 HOLD
Tech 28.0 Fund 40.0 Flow 50.0 Mom 46.3
Weinstein Technical Phase Markup · Hold / add on dips
Price above SMA50, rising 50-day trend (12.1% over 20 days), RSI 64
RSI-14: 64.2 · SMA20: $30.90 · SMA50: $25.86

6-Pillar Scorecard Institutional Category Breakdown (OFIX 3 – 2 KIDS)

Columns: Metric · OFIX · KIDS
1. Valuation Multiples OFIX
Forward P/E N/M N/M
Trailing P/E N/M N/M
PEG Ratio N/M N/M
EV / Revenue 0.3x 3.2x
2. Growth & Scale KIDS
Revenue Growth (YoY) +1.1% +18.6%
Earnings Growth (YoY) +0.0% +0.0%
TTM Revenue (USD) $835M $264M
Market Cap $269.4M $850.2M
3. Profitability & Quality OFIX
Gross Margin 70.8% 73.8%
Operating Margin -2.1% -8.2%
Net Profit Margin -5.4% -12.8%
Return on Equity (ROE) -10.3% -9.8%
4. Balance Sheet & Cash Flow OFIX
Cash Generation (TTM) $41M EBITDA $1.1M EBITDA
Cash Flow Margin 4.9% EBITDA Mgn 0.4% EBITDA Mgn
Net Cash / Leverage $10.54 Book/Sh · -10.3% ROE $12.99 Book/Sh · -9.8% ROE
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning Tie
Options Structure Phase UNCLASSIFIED UNCLASSIFIED
Current IV / %ile 40.1% (3rd %ile) 145.1% (100th %ile)
Put/Call OI Skew N/A N/A
OBV Trend / Tech Phase NEUTRAL · Markdown NEUTRAL · Markup
6. R&D & Supply-Chain Moat KIDS
OpEx & R&D Intensity 72.9% of Rev ($609M) 82.0% of Rev ($217M)
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Cyclical / Execution-Driven Positioning
Supply-Chain Role Medical Devices Operator Medical Devices Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: OFIX (4) vs KIDS (4)
Institutional Metric OFIX KIDS Criterion Row Edge
Market Capitalization
Scale
$269.4M $850.2M Larger Scale KIDS
Trailing P/E Ratio
Valuation
N/M N/M Lower Multiple Tie
Forward P/E Ratio
Valuation
N/M N/M Lower Multiple Tie
Revenue Growth (YoY)
Growth
+1.1% +18.6% Higher Growth KIDS
Operating Margin (TTM)
Profitability
-2.1% -8.2% Higher Margin OFIX
Net Profit Margin
Profitability
-5.4% -12.8% Higher Margin OFIX
Return on Equity (ROE)
Capital Efficiency
-10.3% -9.8% Higher ROE KIDS
52-Week Range Position
Momentum
1% ($6–$16) 90% ($14–$35) Stronger Trend KIDS
Beta / 30D Volatility
Risk Regime
1.05β · 85% Vol 0.81β · 108% Vol Lower Realized Risk OFIX
Unified Institutional Score
Composite Signal
47.8 / 100 (HOLD) 45.1 / 100 (HOLD) Higher Composite OFIX
Trailing 12M Revenue (USD)
Operating Scale
$835M $264M FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
70.8% 73.8% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · 0.3x EV/Rev N/M PEG · 3.2x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
$41M EBITDA ($10.54 Book/Sh · -10.3% ROE) $1.1M EBITDA ($12.99 Book/Sh · -9.8% ROE) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon KIDS +71.28 pp
OFIX: -34.91% · KIDS: +36.37%
3M Horizon KIDS +63.4 pp
OFIX: -36.66% · KIDS: +26.74%
6M Horizon KIDS +115.5 pp
OFIX: -39.1% · KIDS: +76.4%
1Y Horizon KIDS +154.81 pp
OFIX: -55.97% · KIDS: +98.84%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on OFIX vs KIDS. Trailing 12-month operating profitability (OFIX -2.1% vs KIDS -8.2%) and valuation multiples (OFIX N/M vs KIDS N/M Forward P/E) are benchmarked directly in Pillar 4 below.

OFIX ADR TTM Benchmark FX-Normalized USD
TTM Revenue$835M
Gross Margin70.8%
Op. Margin-2.1%
ROE / Fwd P/E-10.3% · N/M
KIDS ADR TTM Benchmark FX-Normalized USD
TTM Revenue$264M
Gross Margin73.8%
Op. Margin-8.2%
ROE / Fwd P/E-9.8% · N/M

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
OFIX UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV 40.1%
IV Percentile 3rd %ile
Put/Call OI Skew N/A
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact OFIX Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
KIDS UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV 145.1%
IV Percentile 100th %ile
Put/Call OI Skew N/A
IV Regime Extreme (>80th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact KIDS Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
OFIX Moat Profile Cyclical / Execution-Driven Positioning
Medical Devices Operator
Competes within the Medical Devices value chain with $269.4M market capitalization and -2.1% operating margin.
OpEx & R&D Reinvestment 72.9% of Rev ($609M)
90D Engineering Disclosures 0 Published
KIDS Moat Profile Cyclical / Execution-Driven Positioning
Medical Devices Operator
Competes within the Medical Devices value chain with $850.2M market capitalization and -8.2% operating margin.
OpEx & R&D Reinvestment 82.0% of Rev ($217M)
90D Engineering Disclosures 0 Published

Investor FAQ OFIX vs KIDS Key Questions & Quantitative Answers

As of Nov 19, 2026, Orthofix Medical Inc. (OFIX) is the stronger overall head-to-head candidate over OrthoPediatrics Corp. (KIDS) in the Tradestie Institutional Equity Comparison Engine, winning 4–4 core matrix metrics and 3–2 across our 6-pillar institutional scorecard (led by Valuation Multiples, Profitability & Quality, Balance Sheet & Cash Flow). OFIX carries a Unified Composite Score of 47.8/100 (HOLD) at $6.34 (N/M Forward P/E, -2.1% operating margin), whereas KIDS carries 45.1/100 (HOLD) at $32.51 (N/M Forward P/E, -8.2% operating margin). Growth vs. Quality Trade-Off: OFIX earns the overall head-to-head edge with a stronger Unified Composite Score (47.8/100 HOLD vs. KIDS 45.1/100 HOLD) and 1.05β · 85% Vol risk profile, whereas KIDS leads top-line expansion (+18.6% YoY revenue growth, N/M PEG, and 2 of 6 institutional pillars) for higher-beta growth mandates. Technical & Structure Timing Caution: OFIX is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 27.4); meanwhile KIDS trades in a Markup technical trend (UNCLASSIFIED options phase, RSI 64.2). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

KIDS leads the Growth & Scale pillar: OFIX posts +1.1% YoY revenue growth and +0.0% YoY earnings growth on $835M TTM revenue (70.8% gross margin, -2.1% operating margin), compared with KIDS at +18.6% YoY revenue growth and +0.0% YoY earnings growth on $264M TTM revenue (73.8% gross margin, -8.2% operating margin). On trailing 12-month operating scale, OFIX generates $835M in USD-normalized revenue versus $264M for KIDS. In operating R&D and SG&A reinvestment, OFIX deploys 72.9% of Rev ($609M) (0 90-day corporate R&D disclosures) versus 82.0% of Rev ($217M) (0 disclosures) for KIDS.

OFIX screens cheaper on headline valuation multiples. OFIX trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and 0.3x EV/Revenue (4.9% EBITDA margin), whereas KIDS trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and 3.2x EV/Revenue (0.4% EBITDA margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against OFIX (-10.3% ROE) versus KIDS (-9.8% ROE) capital efficiency.

In options market volatility and institutional positioning, OFIX carries 40.1% implied volatility (3rd %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (1.05β · 85% Vol realized risk). By comparison, KIDS carries 145.1% implied volatility (100th %ile, Extreme (>80th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.81β · 108% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 19, 2026. For educational research only; not investment advice.